98%
921
2 minutes
20
Methicillin resistant Staphylococcus aureus (MRSA) is a bacterium that is resistant to many antibiotics. Resistance to methicillin is related to production of penicillin binding protein 2a (PBP2a). The currently presented research involves the development of antibody-linked immunoaffinity solid phase microextraction (SPME) sorbents characterized from several aspects that can identify protein PBP2a. The on-sorbent binding constant Kd of monoclonal anti-PBP2a antibody for its antigen protein PBP2a was determined to be 4×10(-10) M. This value was obtained on the basis of the binding curve determined by selective extraction of its antigen PBP2a at different concentrations. The concentration of PBP2a captured by immunoaffinity sorbents was as low as 10ng/mL; lower concentrations could not be tested due to the sensitivity limitation of the LC-MS/MS system available. Surface density was estimated at 59 ng antibody/cm(2). To reduce non-specific binding, especially when the antigen is a protein, bovine serum albumin (BSA) was used to pretreat surfaces. The established immunoaffinity platform technology is expected to provide insights into the development of a practical, specific, sensitive and accurate assay for in vitro and in vivo diagnostics of MRSA.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.chroma.2014.08.042 | DOI Listing |
Bioorg Med Chem
September 2025
Pharmaceutical Chemistry Department, Faculty of Pharmacy, Ain Shams University, Abbassia, Cairo 11566, Egypt. Electronic address:
With the continued upsurge of antibiotic resistance and reduced susceptibility to almost all frontline antibiotics, there is a pressing need for the development of new, effective, and safe alternatives. In this study, a scaffold-hopping strategy was utilized to develop a novel class of penicillin-binding protein 2a (PBP2a) inhibitors, centered around a 4H-chromen-4-one core structure. These newly designed compounds demonstrated strong antibacterial efficacy against methicillin-resistant Staphylococcus aureus (MRSA) and other drug-resistant gram-positive pathogens.
View Article and Find Full Text PDFPharmaceutics
August 2025
Department of Pharmaceutical Chemistry, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Ooty, The Nilgiris 643001, TN, India.
: Antibacterial resistance (ABR) poses a major challenge to global health, with methicillin-resistant (MRSA) being one of the prominent multidrug-resistant strains. MRSA has developed resistance through the expression of Penicillin-Binding Protein 2a (PBP2a), a key transpeptidase enzyme involved in bacterial cell wall biosynthesis. : The objective was to design and characterize a novel small-molecule inhibitor targeting PBP2a as a strategy to combat MRSA.
View Article and Find Full Text PDFMol Divers
August 2025
Department of Microbiology, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, 602105, India.
The alarming rise of multidrug-resistant (MDR) bacterial pathogens poses a significant challenge to current antimicrobial therapy, challenging the development of novel, structurally diverse agents. In this study, a new series of phenylquinoline-triazoles (PQTs) 4a-l was rationally designed and synthesized using a copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC) click chemistry approach. Synthesized PQTs were characterized by standard analytical techniques, including H NMR, C NMR, HRMS, and spectroscopic analyses.
View Article and Find Full Text PDFACS Omega
July 2025
Nitte (Deemed to Be University), Nitte University Centre for Science Education and Research (NUCSER), Department of Bio and Nano Technology, Mangalore 575018, India.
The increasing incidence of drug-resistant bacterial strains, such as methicillin-resistant (MRSA), poses a significant threat to public health owing to their high morbidity and mortality rates. Conventional methods for MRSA detection are expensive and time-consuming, necessitating advanced technological solutions. This study aimed to develop a direct detection strategy for MRSA by using magnetic nanoparticles (MNPs) as capture probes and quantum dots (QDs) as fluorescent detection probes.
View Article and Find Full Text PDFJ Antimicrob Chemother
September 2025
Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi, China.
Objectives: To explore the antibacterial sensitizing effect of DHA27, a derivative of artesunate, on the effect of gentamicin (GEN) against methicillin-resistant Staphylococcus aureus (MRSA) and its molecular mechanism.
Materials And Methods: MICs of drugs against 33 MRSA strains were determined by serial 2-fold dilutions. Fractional inhibitory concentration index (FICI) was determined by chessboard method.